Agree Realty is an integrated real estate investment trust primarily focused on the ownership, acquisition, development and management of retail properties net leased to tenants. The company's assets are held by, and all of its operations are conducted through, directly or indirectly, Agree Limited Partnership, of which the company is the sole general partner and in which it holds a majority interest.

Aldeyra Therapeutics is a biotechnology company engaged in developing and commercializing medicines for patients with immune-mediated diseases. The company's primary product candidate, reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. The company has additional product candidates in development for proliferative vitreoretinopathy and other retinal diseases, autoimmune disease, and cancer. The company has discovered and are developing two additional reactive aldehyde species inhibitors, ADX-103 and ADX-629, for the treatment of retinal disease and autoimmune disease, respectively.

Altair Engineering is a technology company providing software and cloud solutions in the areas of product design and development, cloud computing, and data intelligence. The company's Software segment includes software and software related services. The software component of this segment includes its portfolio of software products including its solvers and optimization technology products. The company's client engineering services (CES), segment provides client engineering services to support its customers with long-term ongoing capability. The company operates its CES business by hiring engineers for placement at a customer site for specific customer-directed assignments.

Antero Resources is an oil and natural gas company engaged in the exploration, development and production of natural gas, natural gas liquids (NGLs), and oil properties. The company focuses on unconventional reservoirs, which can generally be characterized as fractured shale formations. The company's drilling operations are focused in the Marcellus Shale and Utica Shale of the Appalachian Basin. The company's industry segments are: the exploration, development, and production of natural gas, NGLs, and oil; marketing of excess firm transportation capacity; and the gathering and processing of natural gas. All of the company's operations are conducted in the United States.

Athenex is a biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer. The company has three platforms: its Oncology Innovation Platform, dedicated to the research and development of its proprietary drugs; its Commercial Platform, focused on the sales and marketing of its specialty drugs and the market development of its proprietary drugs; and its Global Supply Chain Platform, dedicated to providing a supply of active pharmaceutical ingredients for its clinical and commercial efforts. The company's clinical pipeline includes: Orascovery, Src Kinase inhibition, T-cell Receptor-engineered T-cells, and arginine deprivation therapy.

Barnwell Industries is engaged in the business of: acquiring, developing, producing and selling oil and natural gas in Canada including evaluating proposals by third parties with regard to participation in exploratory and developmental operations elsewhere; investing in land interests in Hawaii; and drilling water and water monitoring wells of varying depths in Hawaii, installing and repairing water pumping systems through its wholly-owned subsidiary, Water Resources International, Inc., which is the distributor for Floway pumps and equipment in the state of Hawaii.

Brainstorm Cell Therapeutics is a biotechnology company engaged in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases including: Amyotrophic Lateral Sclerosis; Progressive Multiple Sclerosis; and Parkinson's disease. NurOwn? technology is based on manufacturing protocol, which induces the differentiation of purified and expanded bone marrow-derived mesenchymal stem cells and consistently generates cells that release multiple neurotrophic factors to modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival and improve neurological function.

CASI Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing therapeutics and pharmaceutical products. The company's primary product and candidates in hematology/oncology include: EVOMELA (Melphalan for Injection), an intravenous formulation of melphalan commercialized in the multiple myeloma treatment setting in the United States; CNCT19, which targets CD19, a B-cell surface protein expressed during all phases of B-cell development and a validated target for B-cell driven hematological malignancies; CID-103, an investigational anti-CD38 monoclonal antibody being developed for the treatment of patients with multiple myeloma.

Cassava Sciences is a clinical-stage drug development company. The company focuses on developing new product candidates and to guide these through various regulatory and development pathways in preparation for their potential commercialization. The company's clinical-stage biopharmaceutical assets include: PTI-125, which is its product candidate for the treatment of Alzheimer's disease; and PTI-125Dx, which it is developing as a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company owns worldwide rights to PTI-125 and PTI-125Dx, without royalty obligations to any third party.

ChemoCentryx is a biopharmaceutical company developing medications targeted at inflammatory disorders, autoimmune diseases and cancer. Each of the company's drug candidates is designed to selectively block a specific chemoattractant receptor. The company's drug candidates are small molecules, which are orally administered. The company's product development portfolio features drug candidates in therapeutic areas of immunology, oncology and immuno-oncology. The company's primary drug candidate is avacopan, an orally-administered molecule that employs a targeted mode of action in the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis and other complement-driven autoimmune and inflammatory diseases.

Cimarex Energy is an independent oil and gas exploration and production company. The company's operations are mainly located in Texas, New Mexico, and Oklahoma. The company's operations are focused in two main areas: the Permian Basin and the Mid-Continent. The company's Permian Basin region encompasses west Texas and southeast New Mexico. The company's Mid-Continent region consists of Oklahoma and the Texas Panhandle.

Conagra Brands is a packaged goods food company. The company's segments are: Grocery and Snacks, which includes branded, shelf stable food products sold in various retail channels; Refrigerated and Frozen, which includes branded, temperature controlled food products sold in various retail channels; International, which includes branded food products sold in retail and foodservice channels outside of the U.S.; Foodservice, which includes customized food products for sale to restaurants and other foodservice establishments; Pinnacle Foods, which includes and private-label food products; and Commercial Foods, which included commercially branded and private label food and ingredients, among others.

Contango Oil & Gas is an independent oil and natural gas company. The company's business is focused on the production from its offshore properties in the shallow waters of the Gulf of Mexico and onshore properties in Texas and Wyoming. The company is also engaged in the exploration, development, exploitation, production, and acquisition of crude oil and natural gas properties in West Texas, the onshore Texas Gulf Coast and the Rocky Mountain regions of the United States.

Corporate Office Properties Trust is a real estate investment trust. Corporate Office Properties, L.P. (COPLP) and subsidiaries is the entity through which the company, the sole general partner of COPLP, conducts almost all of its operations and owns almost all of its assets. The company owns, manages, leases, develops and selectively acquires office and data center properties. The majority of the company's portfolio is in locations that support the United States Government and its contractors that engaged in national security, defense and information technology related activities servicing. The company also owns office properties in select urban/urban-like submarkets in the Greater Washington, DC/Baltimore region.

DISH Network is a holding company. Through its subsidiaries, the company operates two business segments: Pay-TV and Wireless. The company provides pay-TV services under: the DISH? brand, which consists of, among other things, Federal Communications Commission licenses authorizing the company to use direct broadcast satellite and Fixed Satellite Service spectrum, the company's owned and leased satellites, and certain other assets utilized in the company's operations; and the Sling? brand, which consists of, among other things, live-linear streaming over-the-top Internet-based domestic, international and Latino video programming services. In addition, the company invests to acquire certain wireless spectrum licenses and related assets.

FedEx provides transportation, e-commerce and business services through companies under the FedEx brand. These companies are included in the following segments: Federal Express Corporation, including TNT Express B.V., is an express transportation company; FedEx Ground Package System, Inc., which is a provider of small-package ground delivery services; FedEx Freight Corporation, which is a provider of less-than-truckload freight services; and FedEx Corporate Services, Inc., which provides sales, marketing, information technology, communications, customer service, technical support, billing and collections services, and certain back-office functions.

FleetCor Technologies is provider of commercial payment solutions. The company's five primary product lines are Fuel, which provides fuel payment solutions to businesses and government entities who operate vehicle fleets, as well as to main oil companies;Lodging, which provides lodging payment solutions to employees who travel overnight for work purposes; Tolls, which provides an electronic toll and parking payments product; Corporate Payments, which include virtual cards, purchasing cards, travel and entertainment cards; and Gift, which provides gift card product management and processing services. Additionally, the company provides other payment products including fleet maintenance and employee benefits.

Globalstar provides mobile satellite services including voice and data communications services via satellite. The company provides the following communications services via satellite: two-way voice communication and data transmissions using mobile or fixed devices including its GSP-1700 phone; one-way or two-way communication and data transmissions using mobile devices, including its SPOT family of products such as SPOT X?, SPOT Gen3 and Trace; and one-way data transmissions using a mobile or fixed device that transmits its location and other information to a central monitoring station, including its commercial Simplex products, such as its battery and solar-powered SmartOne, STX-3 and STINGR.

GlycoMimetics is a clinical stage biotechnology company focused on the discovery and development of glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a main role. The company is developing uproleselan, a specific E-selectin inhibitor, to be used in combination with chemotherapy to treat patients with acute myeloid leukemia and other hematologic cancers. The company is also developing an additional drug candidate, GMI-1359, that simultaneously targets both E-selectin and a chemokine receptor known as CXCR4.

Good Times Restaurants operates and franchises Bad Daddy's Burger Bar restaurants (Bad Daddy's) and Good Times Burgers & Frozen Custard (Good Times) restaurants. Bad Daddy's and Good Times are two distinctly different, yet complementary, restaurant concepts. Bad Daddy's operates in the casual dining segment of the restaurant industry. Bad Daddy's operates all of its company-owned restaurants under a table service / full-bar service model. The menu is comprised of burgers, salads, sandwiches, and appetizers. Good Times is a quick service restaurant concept offering hand crafted products. Good Times provides a menu of Angus beef and chicken.

Groupon operates online local commerce marketplaces that connect merchants to consumers by providing goods and services through its websites, groupon.com, and its mobile applications. The company provides goods and services in three categories: Local, which includes offerings from local and national merchants, and local events; Goods, which provides customers the ability to find discounted merchandise across multiple product lines, including electronics, sporting goods, jewelry, toys, household items and apparel; and Travel, which features travel offers at both discounted and market rates, such as hotels, airfare and package deals covering both domestic and international travel.

Impac Mortgage Holdings is an independent residential mortgage lender which originates, sells and services residential mortgage loans. The company's operating segments include: Mortgage Lending, which primarily originates, sells and services conforming agency and government insured residential mortgage loans originated or acquired through its retail (consumer direct), wholesale, and correspondent channels; Real Estate Services, which provides loss mitigation and real estate services; and the Long-Term Mortgage Portfolio, which includes adjustable rate and, to a lesser extent, fixed rate Alt-A single-family residential mortgages and commercial (primarily multifamily residential loans) mortgages.

Innovative Industrial Properties is a holding company. Through its subsidiaries, the company is a real estate investment trust focused on the acquisition, ownership and management of industrial properties leased to state-licensed operators for their regulated state-licensed cannabis facilities. The company leases its properties on a triple-net lease basis, where the tenant is responsible for various aspects of and costs related to the property and its operation during the lease term, including structural repairs, maintenance, taxes and insurance. The company conducts its business through a real estate investment trust, in which the company's properties are owned by its operating partnership, IIP Operating Partnership, LP.

Jernigan Capital is a commercial real estate company that invests primarily in new or recently-constructed and opened self-storage facilities located in dense urban submarkets within U.S. metropolitan statistical areas (MSAs). The company conducts its investment activities through its operating company, Jernigan Capital Operating Company, LLC. The company focuses on originating the following types of investments: Development Property Investments, which finances ground-up construction of self-storage facilities or self-storage conversion or redevelopment opportunities within the MSA; Wholly-Owned Property Investments; and Bridge Investments.

Kingstone Companies is an insurance holding company. Through its wholly-owned subsidiary, Kingstone Insurance Company (KICO), the company provides property and casualty insurance products to individuals and small businesses. KICO is a licensed property and casualty insurance company in New York, New Jersey, Connecticut, Massachusetts, Pennsylvania, Rhode Island, Maine and New Hampshire. The company's product lines include: personal lines, which provide homeowners and dwelling fire multi-peril, cooperative/condominiums and personal umbrella policies; commercial liability, which provides businessowners policies; and livery physical damage, which writes for-hire vehicle physical damage only policies.

Lee Enterprises is a provider of local news and information, and a platform for advertising, in the markets it serves. The company's products provide print and digital editions, and its content and advertising is available through its websites and mobile apps. The company provides marketing services, mainly through its digital marketing agency, Amplified Agency, and through one of its subsidiaries, TownNews, the company provides web hosting and content management services for its media operations and other content producers. The company's also provides commercial printing, distribution of third party publications and management services to other local media operations.

Lovesac is a technology omni-channel company that designs, manufactures and sells furniture comprised of couches called Sactionals and foam beanbag chairs called Sacs. The company markets and sells its products through showrooms and online sales.

Marrone Bio Innovations makes bio-based pest management and plant health products. Bio-based products are comprised of naturally occurring microorganisms, such as bacteria and fungi, and plant extracts. The company primarily sells its products to the crop protection market and also have one plant health product, Haven, that reduces plant stress in drought and intense sunlight. The company's product lines are Regalia, for controlling plant disease and increasing plant health, Grandevo and Venerate, for insect and mite control, Majestene and its turf and ornamentals counterpart brand Zelto, for nematode control and Stargus and its row crop counterpart brand Amplitude, for downy mildew and white mold control.

MEI Pharma is a late-stage pharmaceutical company focused on development and oncology capabilities to identify and develop therapies for the treatment of cancer. The company has four clinical-stage development programs with approaches to inhibiting cancer, including epigenetics, cell signalling and cancer metabolism: ME-401, an oral phosphatidylinositol 3-kinase delta inhibitor; Voruciclib, an oral cyclin-dependent kinase inhibitor; ME-344, a mitochondrial inhibitor targeting the oxidative phosphorylation complex; and Pracinostat, an oral histone deacetylase inhibitor being evaluated in a pivotal Phase 3 global registration clinical trial for the treatment of adults with acute myeloid leukemia.

National Beverage is a holding company. Through its subsidiaries, the company develops, produces, markets and sells a range of sparkling waters, juices, energy drinks and carbonated soft drinks. The company's brands consist of beverages for active and health-conscious consumer (Power+ Brands) including sparkling waters, energy drinks, and juices. The company's portfolio of Power+ Brands includes LaCroix?, LaCroix Curate?, LaCroix NiCola? and Shasta? Sparkling Water products; Rip It? energy drinks and shots; and Everfresh?, Everfresh Premier Varietals? and Mr. Pure? 100% juice and juice-based products. Additionally, the company produces and distributes carbonated soft drinks including Shasta? and Faygo? brands.

On Track Innovations and its subsidiaries are principally engaged in the field of design and development of cashless payment solutions. Co. operates in two segments: Retail and Mass Transit Ticketing; which includes selling and marketing variety of products for cashless payment solutions for the retail market and mass transit ticketing; and Petroleum, which includes manufacturing and selling of fuel payment and management solutions. In addition, certain products for the medical industry and other secure smart card solutions are classified under Other segment. Co. focuses on providing cashless payment solutions based among other things on its contactless near field communications technology.

PolarityTE is a commercial-stage biotechnology and regenerative biomaterials company focused on discovering, designing and developing a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering and material sciences. The company's tissue product, SkinTE is registered with the United States Food and Drug Administration, and is commercially available for the repair, reconstruction, replacement and regeneration of skin in patients who have a need for treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts.

Provention Bio is a clinical stage biopharmaceutical company focused on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. The company's principal product candidates include: PRV-031 (teplizumab, anti-CD3 mAb) for the interception of type 1 diabetes; PRV-015 (anti-IL-15 mAb) for the treatment of gluten-free diet non-responding celiac disease; PRV-6527 (oral CSF-1R inhibitor) for the treatment of Crohn's disease; PRV-300 (anti-TLR3 mAb) for the treatment of ulcerative colitis; and PRV-3279 (humanized anti-CD32B and CD79B bispecific) for the treatment of lupus.

RiceBran Technologies is an ingredient company serving food, animal nutrition and specialty markets focused on processing and marketing of healthy, natural and nutrient dense products derived from raw rice bran, an underutilized by-product of the rice milling industry. The company converts raw rice bran into various products including: stabilized rice bran (SRB); RiBalance, a rice bran nutritional package derived from further processing of SRB; RiSolubles, a nutritious, carbohydrate and lipid rich fraction of RiBalance; RiFiber, a protein and fiber rich insoluble derivative of RiBalance; and its family of ProRyza products, which includes derivatives composed of protein and protein/fiber blends.

Schmitt Industries is engaged in providing precision test, measurement and process control products. The company has the following segments: Balancer, which designs, manufactures and sells computer-controlled vibration detection, balancing and process control systems for the worldwide machine tool industry, particularly for grinding machines; and Measurement, which through its wholly owned subsidiary, Schmitt Measurement Systems, Inc., manufacturers and sells products in two primary product lines, Acuity and Xact. Acuity sells products, solutions and services that includes laser and white light sensor distance. Xact includes satellite focused remote tank monitoring products.

Spirit Airlines is an airline that provides travel opportunities principally throughout the domestic United States, the Caribbean and Latin America. The company's ultra low-cost carrier business model provides customers low, unbundled base fares with a range of optional services, allowing customers to choose their options. The majority of the company's tickets are sold through direct channels including online via www.spirit.com, its call center and its airport ticket counters, with www.spirit.com being the primary channel. The company also partners with a number of third parties to distribute its tickets, including online and travel agents and electronic global distribution systems.

Syros Pharmaceuticals is a biopharmaceutical company engaged in the non-coding regulatory region of the genome to develop a new wave of medicines that control the expression of genes. The company's primary product candidates are: SY-1425, a selective retinoic acid receptor alpha agonist that is used to treat acute myeloid leukemia patients; SY-1365, a selective inhibitor of cyclin-dependent kinase 7 (CDK7), that is being evaluated in a Phase 1 clinical trial in patients with advanced solid tumors; and SY-5609, a CDK7 inhibitor that can be administered orally, which is being evaluated in investigational new drug application, enabling preclinical studies.

XOMA is a biotech royalty aggregator with a portfolio of pre-commercial therapeutic candidates. The company's monoclonal antibodies and technologies product candidates are: IL-2, which targets Interleukin 2 as a therapy for metastatic melanoma and renal cell carcinoma; PTH1R, an anti-parathyroid receptor pipeline that includes several functional antibody antagonists targeting PTH1R, a G-protein-coupled receptor involved in the regulation of calcium metabolism; XMetA, an insulin receptor-activating antibody designed to provide long-acting reduction of hyperglycemia in Type 2 diabetic patients; X213, an allosteric inhibitor of prolactin action.